1. Introduction {#s0005}
===============

The global prevalence of diabetes is on a steady rise. A recent analysis of diabetes worldwide reported that the number of adults aged 18 years and over globally, living with diabetes substantially increased from 108 million in 1980 to 422 million as of the year 2014, almost a 400% increase ([@bb0250]). Population growth and population aging have also contributed to the number of diabetes cases worldwide ([@bb0250]). Diabetes is recognized as an important determinant of premature death, disability, morbidity, and increased health-system costs ([@bb0120]; [@bb0315]). Depressive symptoms and major depressive disorder (MDD) are more common in people with diabetes compared to those without diabetes. Recent studies revealed that depression is twice as prevalent among individuals with Type 2 diabetes compared to controls ([@bb0030]; [@bb0015]). Some researchers have argued that diabetes precedes depression and increases the risk of developing depression due to the psychological trauma following diagnoses of diabetes and its burdens such as hyperglycemia leading to altered glucose transport or treatment of the disease itself or both combined as they pose significant challenges for clinical practice ([@bb0030]; [@bb0105]). This line of argument was challenged by recent longitudinal studies that found that depression may be a risk factor for diabetes ([@bb0030]; [@bb0125]) but diabetes may not necessarily predict depression or diabetes may just be modestly associated with depression ([@bb0105]). A recent WHO study reported individuals with both conditions are more likely to rate their health as poor more in comparison to individuals with depression only or other chronic conditions only ([@bb0235]).

Depression, a common and often recurrent disorder has a number of risk factors which have been documented in the literature. Some of these include comorbidities with other conditions ([@bb0335]), other mental illnesses ([@bb0365]), family history of depression and mental illness ([@bb0240]), adverse events of childhood ([@bb0190]), prior history of depression ([@bb0155]), and treatment of depression and outcomes of treatment ([@bb0220]), physical inactivity ([@bb0205]), female gender, younger adults, smoking and having a chronic disease ([@bb0210]), and unhealthy eating styles ([@bb0290]). Depression is also a large burden on most economies ([@bb0095]) and leads to increased mortality ([@bb0070]; [@bb0175]). Regular screening for depression is recommended by most clinical guidelines for diabetes ([@bb0165]; [@bb0245]).

Most studies in this subject utilized cross-sectional study designs which limits causal inferences, making recommendations for practice problematic ([@bb0030]; [@bb0015]). A number of systematic reviews and meta-analyses ([@bb0185]; [@bb0085]; [@bb0215]; [@bb0370]; [@bb0340]) found that depression was associated with an increased risk of incident diabetes while earlier systematic reviews and meta-analysis found the reverse that is individuals with diabetes had a modestly increased risk of developing depression ([@bb0215]; [@bb0260]; [@bb0300]; [@bb0325]; [@bb0330]). The possibility of a bidirectional relationship has gained much attention in recent years become the focus of a number of longitudinal prospective studies, literature reviews, systematic reviews and meta-analysis ([@bb0280]; [@bb0375]; [@bb0020]; [@bb0140]; [@bb0305]).

A variety of biological pathways that have been mooted as being shared origins for depression and diabetes including innate immunity and inflammation, the hypothalamic --pituitary-adrenal-axis (HPA axis), insulin resistance and secretion, circadian rhythms, and anti-depressant medications. In-utero and early childhood experiences are also posited as a common pathway linking depression and diabetes, particularly Type 2 diabetes ([@bb0150]; [@bb0230]).

In previous reviews, the authors did not distinguish between studies that used diagnostic blood tests to diagnose diabetes and those that used self-report. Studies using self-report usually underestimate diabetes prevalence in contrast to studies that use diagnostic blood tests ([@bb0060]). In addition, there is little information on the potential impact of reducing diabetes prevalence in decreasing the incidence of depression in a population or vice versa. Population attributable fractions (PAFs) are used to indicate the proportional reduction of a disease in a population (incidence or mortality) that would occur if exposure to a risk factor were reduced to an ideal exposure level ([@bb0295]). PAFs are recognized as an effective tool for measuring the potential effects of risk factors reduction on disease occurrence ([@bb0310]; [@bb0055]; [@bb0040]; [@bb0205]; [@bb0210]). Northridge ([@bb0255]) writes that PAFs can assist policy-makers in judging priorities for public health action, intervention planning, and decision-making.

The current study aims to: (1) systematically examine the relationship between diabetes, measured using both self-report of doctor\'s diagnoses and blood tests, and depression risk in longitudinal cohort studies and (2) provide estimates of by how much the population incidence of depression would be reduced if diabetes was reduced. While a previous study ([@bb0260]) sub-analyzed their results according to the outcome (depression), our analyses were based on sub-analysis according to the method of diagnoses of the exposure of interest (diabetes). What this analysis adds new is the use of only longitudinal cohort studies, separate analysis of studies that used diagnostic blood tests versus self-report of doctor\'s diagnoses as measures of diabetes, and the calculation of the potential population\'s effects on depression incidence of reducing diabetes.

2. Methods -- systematic review and meta-analysis {#s0010}
=================================================

The current systematic review and meta-analysis follow the PRISMA guidelines, 2009 revision ([@bb0225]), and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) recommendations ([@bb0320]). The Newcastle--Ottawa Scale criteria were used to characterize study quality ([@bb0350]).

2.1. Search strategy {#s0015}
--------------------

A computerized search for published articles was conducted in Medline/PubMed, EMBASE, PsycINFO, and Cochrane Library databases between January 1990 and December 2017. A manual search was done on other resources for additional relevant studies. We also scanned through the reference lists of the selected articles, as well as review articles on the topic, and also screened for grey literature.

To get a maximum number of relevant citations, we conducted three steps search process under the MeSH terms using relevant keywords or title search. In step I, depression was searched as follows; "depression OR major depressive disorder OR MDD OR depressive disorders OR depression symptoms OR depressive symptoms". At step II, diabetes was also searched as "diabetes mellitus OR diabetes OR type 2 diabetes OR diabetes symptoms". In step III, we combined step I AND step II AND (cohort studies OR prospective OR retrospective OR follow up OR follow-up OR longitudinal OR panel OR incident OR concurrent OR incidence) for study literature retrieval.

2.2. Inclusion and exclusion criteria {#s0020}
-------------------------------------

The following inclusion and exclusion criteria for article selection were used: 1) published between (January 1990 and December 2017); 2) written in English; 3) cohort study designs; 4) use clear diagnostic criteria for depression measured by the use of Centre for Epidemiologic Studies Depression Scale Questionnaire (CES-D), Hospital Anxiety and Depression Scale Questionnaire (HADS), Beck Depression Inventory (BDI), a structured diagnostic interview, or other measurements such as antidepressants use ([@bb0025]; [@bb0355]),; 5) explicit exclusion of patients with depression at baseline; 6) give clear information on the diagnosis of diabetes used either a self-report of a doctor\'s diagnosis or a diagnostic blood test to measure diabetes;7) provided a statistical indicator (relative risk, odds ratio, hazard ratio) or original data to estimate the relationship between diabetes and depression; 8) controlled for confounders by using statistical adjustment in the analysis or matching in the study design. We excluded studies that were: 1) case reports, cross-sectional, case-control, a chart review, or 2) did not provide enough information on key inclusion criteria.

2.3. Selection of articles {#s0025}
--------------------------

Authors (B.C. and M.L.) independently screened abstracts and full texts and extracted data from the eligible articles. In instances where disagreements emerged, reviewers consulted each other and they were resolved through discussion. The 14,879 titles retrieved in our initial search were later reduced to 7235 after duplicates were excluded. After title review 458 potentially relevant articles remained. After abstract screening, the full-text of 253 articles was retrieved for review. One author of a selected article was contacted for a full-text article after it could not be retrieved online. It was directly sent to us. After full-text review, 20 articles met the selection criteria and were included in the study. [Fig. 1](#f0005){ref-type="fig"} provides details on the articles selection process. Data on author, publication year, journal, sample size, methods, indicators, outcomes, adjustments, study design, and results were extracted independently by two authors \[B.C. and M.L.\].Fig. 1PRISMA flow diagram -- Diabetes and incidence of depression in later life.Fig. 1

2.4. Data synthesis {#s0030}
-------------------

The analyses generated pooled estimates of the effects of diabetes on depression risk in general and by study design and method of diabetes diagnosis. We evaluated heterogeneity with DerSimonian and Laird *I*^2^ statistics for each analysis category ([@bb0145]). In order to provide a visual assessment of publication bias, funnel plots and Egger\'s tests were used ([@bb0100]). A Begg-adjusted rank correlation test was also used to check for publication bias. If these tests showed non-significant heterogeneity, we used fixed-effects model, otherwise, a more conservative random-effects model was used. Sensitivity analysis was performed to assess the influence of each individual study on overall estimates by recalculating odds ratios with studies being removed one at a time. The quality of each study was rated according to the Newcastle--Ottawa Scale. Finally, the influence of each study design and method of diabetes diagnosis on depression incidence and the impact of study quality on results was investigated using meta-regression analyses. Stata v. 14.2 statistical software (StataCorp., USA) was used for the analyses.

2.5. Calculation of projected effects -- population attributable fractions (PAFs) {#s0035}
---------------------------------------------------------------------------------

PAF represents the proportional reduction in disease risk that would be achieved by removing an exposure or reducing it to a specified level. It estimates the proportion of a disease in a population that is potentially attributable to a given risk factor ([@bb0045]). PAFs estimate the strength of association between a risk factor and a disease outcome. We used the following formula derived from the literature ([@bb0295]; [@bb0310]; [@bb0040]).$${PAF} = p\left( {\text{OR} - 1} \right)$$$$p\left( {\text{OR} - 1} \right) + 1$$where *p* represents the population prevalence of the exposure and OR is the pooled odds ratio of outcomes given different categories of diabetes diagnosis and the different study designs. We used the worldwide prevalence estimates of diabetes to generate PAFs for prospective and retrospective studies as well as self-reported doctor\'s diagnosis and diagnostic blood test for diabetes ([@bb0250]).

Finally, we estimated the total number of depression cases attributable to diabetes by multiplying PAF estimates and the present number of cases worldwide. We also calculated the number of cases that could potentially have been prevented if the prevalence of diabetes were 10% or 25% lower. Confidence ranges for the PAF estimates were calculated.

3. Results {#s0040}
==========

We retrieved 14,879 citations in our initial search which later reduced to 7235 titles after duplicates were excluded. Another 6777 articles were removed after title review which resulted in 458 potentially relevant articles remaining. A little over half of the articles (253) were maintained after the abstract screening. A final list of 20 articles that met the criteria for meta-analysis after full-text screening and were included in the study ([@bb0035]; [@bb0080]; [@bb0090]; [@bb0125]; [@bb0130]; [@bb0135]; [@bb0160]; [@bb0180]; [@bb0195]; [@bb0285]; [@bb0280]; [@bb0115]; [@bb0200]; [@bb0105]; [@bb0275]; [@bb0065]; [@bb0005]; [@bb0110]; [@bb0265]). [Table 1](#t0005){ref-type="table"} shows the detailed summary of study attributes and data on the characteristics of the reviewed articles. Articles were assess based on; population representativeness, accuracy in selecting non-exposed groups, the absence of the outcome of interest before the start of the study, proper assessment of both exposure and outcome, adequate follow-up period for the outcome to occur, appropriate statistical analysis, control for confounding and other related information. This quality is evident in the fact that none of the study characteristics examined had any impact on observed odds ratios in any of our analyses and by the absence of any publication bias.Table 1Summary of studies\' attributes.Table 1First AuthorYearSettingStudy designSample/data sourceSample sizeAge of exposureFollow--up\
(years)Ascertainment of exposureAssessment of health outcomeDepression criteria[a](#tf0005){ref-type="table-fn"}Asamsama et al. ([@bb0035])2015USAProspectiveBiopsychosocial Religion and Health Study of Adventist Adults4152≥613Self-report of doctor\'s diagnosisCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 16Bisschop et al. ([@bb0050])2004NetherlandsProspectiveLongitudinal Aging Study Amsterdam183955--856Self-report of doctor\'s diagnosisCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 16Chen et al. ([@bb0080])2013TaiwanProspectiveNational Health Insurance claims of the General population33,914≥357Self-report of doctor\'s diagnosisMedical reportsPhysician-diagnosed depressionde Jonge et al. ([@bb0090])2006SpainProspectiveCommunity based study of the elderly4757≥555Self-report of doctor\'s diagnosisStructured Interview (GMS & AGECAT)GMS-AGECAT ≥3Engum ([@bb0105])2007NorwayProspectiveNord-Trøndelag Health Study37,291≥3010Self-report of doctor\'s diagnosisHospital Anxiety and Depression Scale QuestionnaireHADS-D scale score ≥ 8Garcia et al. ([@bb0115])2016USAProspectiveSacramento Latino Study on Aging1583≥6010Fasting blood glucoseCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 16Golden et al. ([@bb0125])2008USAProspectiveMulti-Ethnic Study of Atherosclerosis520145--843Fasting Plasma Glucose (FPG)Centre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 16Hamer et al. ([@bb0130])2011EnglandProspectiveEnglish Longitudinal Study of Aging (ELSA)4338≥622Fasting Plasma Glucose (FPG)Centre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 4Hasan et al. ([@bb0135])2015AustraliaProspectiveAustralian Pregnancy and Birth Cohort Study2791Agenotspecified6Self-report of doctor\'s diagnosisDelusions-Symptoms-States-Inventory (DSSI)DSSI score ≥ 4Icks et al. ([@bb0160])2013GermanyProspectivePopulation-based Heinz Nixdorf Recall Study363345--755Fasting blood glucoseCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 17Kim et al. ([@bb0180])2006South KoreaProspectiveCommunity Residents aged 65+521≥652Self-report of doctor\'s diagnosisStructured Interview (GMS & AGECAT)GMS-AGECAT ≥3Luijendijk et al. ([@bb0195])2008NetherlandsProspectiveRotterdam Study of Community dwelling elderly2931≥615Fasting Plasma GlucoseCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 16Maraldi et al. ([@bb0200])2007USAProspectiveHealth, Aging & body composition study252270--795.9Self-report of doctor\'s diagnosisCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 10Pan et al. ([@bb0280])2010USAProspectiveNurses\' Health Study Cohort56,85750--7510Self-report of doctor\'s diagnosisAntidepressant medications (drugs)Physician-diagnosed depression or antidepressant usePalinkas et al. ([@bb0275])2004USAProspectiveAdult population of Rancho Bernardo971≥508Oral Glucose Tolerance Test (OGTT)Beck Depression Inventory (BDI)BDI score ≥ 11Polsky et al. ([@bb0285])2005USAProspectiveHealth & Retirement Study of elderly838751--618Self-report of doctor\'s diagnosisCentre for Epidemiologic Study Depression Scale QuestionnaireCES-D scale score ≥ 5Aarts et al. ([@bb0005])2009NetherlandsRetrospectiveRegistration Network Family Practice Study24,556≥407.8Fasting Plasma Glucose (FPG)Diagnostic interview by a specialistPhysician-diagnosed depressionBrown et al. ([@bb0065])2006CanadaRetrospectivePopulation-based Saskatchewan Residents88,776≥204.5Self-report of doctor\'s diagnosisAntidepressant medications (drugs)Physician-diagnosed depression or antidepressant useFinkelstein et al. ([@bb0110])2003USARetrospectiveMedicare Standard Analytic Files237,864≥656Self-report of doctor\'s diagnoseMedical reportsPhysician-diagnosed depressionO\'Connor et al. ([@bb0265])2009USARetrospectiveHealth Partners Medical Group (HPMG)28,288≥402Self-report of doctor\'s diagnoseAntidepressant medications (drugs)Physician-diagnosed depression or antidepressant use[^1]

The reviewed articles were categorized into four groups for the analyses: (1) prospective studies and depression incidence; (2) retrospective studies and depression incidence; (3) self-reported doctor\'s diagnosis of diabetes and depression incidence; (4) blood test diagnosis of diabetes and depression incidence. Some studies are involved in multiple separate analyses as their available data permitted.

3.1. Relationship between diabetes and depression in prospective studies {#s0045}
------------------------------------------------------------------------

Sixteen articles ([@bb0050]; [@bb0035]; [@bb0080]; [@bb0090]; [@bb0125]; [@bb0130]; [@bb0135]; [@bb0160]; [@bb0180]; [@bb0195]; [@bb0285]; [@bb0280]; [@bb0115]; [@bb0200]; [@bb0105]; [@bb0275]) used prospective study designs in examining the relationship between diabetes and depression incidence. Most of these studies used the Epidemiologic Studies Depression Scale Questionnaire (CES-D) to measure depression. They had a median follow-up period of 5.95 years. Eight studies([@bb0080]; [@bb0090]; [@bb0130]; [@bb0135]; [@bb0195]; [@bb0280]; [@bb0115]; [@bb0200]) with a median follow-up of 5.95 years reported a significant association between diabetes and depression incidence, the other eight studies ([@bb0050]; [@bb0035]; [@bb0125]; [@bb0160]; [@bb0180]; [@bb0285]; [@bb0105]; [@bb0275]) with a median follow-up of 5.5 years reported no association.

[Fig. 2](#f0010){ref-type="fig"}a presents the individual study, pooled estimates, and funnel plots for this group of studies. A random-effects model was used. The pooled OR for incident depression among respondents with diabetes in these prospective studies was 1.34 (95% CI 1.14--1.57, χ^2^ = 76.65, I^2^ = 80.4%, *p* \< .001) clearly indicating that diabetes was a risk factor for depression. [Fig. 2](#f0010){ref-type="fig"}a shows all the studies were within the domain which represents 95% CI limits. No evidence of asymmetry or publication bias was found (Egger\'s test, *p* = .053). Sensitivity analysis yielded ORs ranging from 1.29 (95% CI 1.14--1.47) to 1.39 (95% CI 1.19--1.62) in these prospective studies.Fig. 2a Prospective studies and risk of depression.b: Retrospective studies and risk of depression.c: Self-report doctors\' diagnosis of diabetes and risk of depression.d: Blood test diagnoses of diabetes and risk of depression.Fig. 2

3.2. Relationship between diabetes and depression in retrospective studies {#s0050}
--------------------------------------------------------------------------

Four articles ([@bb0065]; [@bb0005]; [@bb0110]; [@bb0265]) used retrospective study designs to examine diabetes and incident depression relationship. Depression was assessed through antidepressants use, medical reports or structured interviews by a specialist. The median follow-up time was 5.25 years. Two studies ([@bb0005]; [@bb0110]) with a median follow-up of 6.9 years reported an association while the two other studies ([@bb0065]; [@bb0265]) with an average follow-up of 3.25 years did not find an association. [Fig. 2](#f0010){ref-type="fig"}b shows the individual study and pooled estimates, and funnel plots. A random-effects model was used. The pooled OR for these studies was 1.30 (95% CI 1.05--1.62, χ^2^ = 46.71, I^2^ = 93.6%, *p* \< .000). No asymmetry or publication bias was found (Egger\'s test, *p* = .85). Sensitivity analyses for the retrospective studies reported ORs ranging from 1.23 (95% CI 0.95--1.60) to 1.46 (95% CI 1.34--1.59).

3.3. Relationship between self-report of doctors\' diagnosis of diabetes and depression {#s0055}
---------------------------------------------------------------------------------------

Thirteen articles ([@bb0050]; [@bb0035]; [@bb0080]; [@bb0090]; [@bb0135]; [@bb0180]; [@bb0285]; [@bb0280]; [@bb0200]; [@bb0105]; [@bb0065]; [@bb0110]; [@bb0265]) measured diabetes using self-reported doctor\'s diagnosis of diabetes. [Fig. 2](#f0010){ref-type="fig"}c presents the individual study ORs, pooled estimates, and funnel plots. A random-effects model was used. The pooled OR for incident depression for these studies was 1.37 (95% CI 1.17--1.160, χ^2^ = 127.51, I^2^ = 90.6%, *p* \< .001). No asymmetry or publication bias was found (Egger\'s test, *p* = 0. 848). Sensitivity analysis produced ORs ranging from 1.32 (95% CI 1.15--1.51) to 1.43 (95% CI 1.26--1.63).

3.4. Relationship between diabetes and depression in studies using a diagnostic blood test to diagnose diabetes {#s0060}
---------------------------------------------------------------------------------------------------------------

Seven articles ([@bb0125]; [@bb0130]; [@bb0160]; [@bb0195]; [@bb0115]; [@bb0275]; [@bb0005]) were included in this sub-analysis. A random-effects model was used. [Fig. 2](#f0010){ref-type="fig"}d reports individual study estimates, pooled estimates, and funnel plots. The pooled OR for incident depression in these studies was 1.25 (95% CI 1.04--1.52, χ^2^ = 12.76, I^2^ = 53.0%, *p* = .047). No asymmetry or publication bias was present (Egger\'s test = 0. 896). Sensitivity analysis yielded ORs ranging from 1.17 (95% CI 1.0--1.38) to 1.31 (95% CI 1.06--1.62).

3.5. Prospective studies of diabetes and depression that used self-report of doctors\' diagnosis of diabetes {#s0065}
------------------------------------------------------------------------------------------------------------

Ten prospective studies ([@bb0050]; [@bb0035]; [@bb0080]; [@bb0090]; [@bb0135]; [@bb0180]; [@bb0285]; [@bb0200]; [@bb0105]) used self-report of a doctors\' diagnosis of diabetes. [Fig. 3](#f0015){ref-type="fig"}a shows that in prospective studies that used self-report diagnosis of diabetes were 1.39 times (95% CI 1.14--1.68, χ^2^ = 54.28, I^2^ = 83.4%, *p* \< .001) more likely to report incident depression compared to those without diabetes. There was some marginal evidence of asymmetry and publication bias (see [Table 2](#t0010){ref-type="table"}).Fig. 3a. Prospective studies and self-report measures of diabetes.b: Prospective studies and blood test measures of diabetes.c: Retrospective studies and self-report doctors\' diagnosis measures of diabetes.Fig. 3Table 2Summarizes the results of our meta-analysis.Table 2Study groupOdds ratios (OR)95% Confidence interval (CI)*p*-ValueProspective studies1.341.14--1.57\<0.001Retrospective studies1.301.05--1.62\<0.001Studies using self-report1.371.17--1.60\<0.001Studies using blood tests1.251.04--1.520.047Prospective studies using self-report measure1.391.14--1.68\<0.001Prospective studies using blood test measure1.260.98--1.610.026Retrospective studies using self-report measure1.321.02--1.72\<0.001

3.6. Prospective studies of diabetes and depression in studies that use a blood test measure of diabetes {#s0070}
--------------------------------------------------------------------------------------------------------

Six prospective studies measured diabetes-depression relationship using diagnostic blood tests ([@bb0125]; [@bb0130]; [@bb0160]; [@bb0195]; [@bb0115]; [@bb0275]). In comparison to prospective self-report studies these studies did not show diabetes as a risk factor for incident depression (OR = 1.26, 95% CI 0.98--1.61, χ^2^ = 12.78, I^2^ = 60.9%, *p* = .026). The non-significant results are shown in [Fig. 3](#f0015){ref-type="fig"}b. However, three of the six studies reported a positive relationship. There was no evidence of asymmetry or publication bias.

3.7. Retrospective studies of diabetes and depression in studies using self-report of doctors\' diagnoses of diabetes {#s0075}
---------------------------------------------------------------------------------------------------------------------

Three of these four retrospective studies ([@bb0065]; [@bb0110]; [@bb0265]) used self-report diagnosis of diabetes to examine the diabetes-depression relationship. The pooled odds for these studies showed that individuals with diabetes were 1.32 times (95% CI 1.02--1.72, χ^2^ = 46.66, I^2^ = 95.7%, *p* \< .001) more likely to report incident depression (see [Fig. 3](#f0015){ref-type="fig"}c). Asymmetry and publication bias was evident. The one study ([@bb0005]) that used a diagnostic blood test measure reported an OR of 1.25 (CI 1.01--1.54).

In summary, our analyses show that although there is some variability in findings by study method the pooled ORs emerging from this group of studies generally support findings that diabetes is a risk factor for depression ([Table 2](#t0010){ref-type="table"}).

3.8. Projected effects (PAFs) of risk reduction {#s0080}
-----------------------------------------------

### 3.8.1. Prevalence of diabetes and PAFs {#s0085}

As of 2016, the worldwide estimated prevalence of diabetes was 8.5% (422 million) ([@bb0250]) whilst that of depression was estimated to affect 350 million ([@bb0360]). The PAF estimates used here for the effect of diabetes on the incidence of depression is 2.73%, which indicates that over (9.55 million) of depression cases are potentially attributable to diabetes globally ([Table 3](#t0015){ref-type="table"}). If the global prevalence of diabetes was reduced by 10%, we estimated that there would be (930,000) fewer depression cases worldwide, whereas a 25% reduction in diabetes could reduce depression prevalence by (2.34 million) cases ([Fig. 4](#f0020){ref-type="fig"}). It should be noted that the number of cases attributable to diabetes may be overestimated as a result of co-morbidity with other chronic diseases. Many diseases are caused by multiple risk factors, and individual risk factors may interact in their impact on overall risk of disease. Using prospective study values it is estimated that 2.81% (over 9.83 million) of depression cases in the world are potentially attributable to diabetes. If the incidence of diabetes was reduced by 10%, 960,000 cases of depression could potentially be reduced; whilst a 25% reduction in the incidence of diabetes would result in reducing the incidence of depression by 2.41 million cases worldwide. Using retrospective study values yields slightly lower estimates of reduction in the incidence of depression. Estimates from studies using self-report and blood test measure again yield sizeable reductions in depression incidence (see [Fig. 4](#f0020){ref-type="fig"}).Table 3Estimated depression cases attributable to diabetes presence worldwide by type of study design.Table 3Pooled OR (95% CI)Population prevalence of diabetesPAF (confidence range)Number of cases attributable-millions (confidence range)Worldwide1.33 (1.18--1.51)8.50%2.73% (1.51--4.15)9.55 (5.27--14.54)Prospective and depression1.34 (1.14--1.57)8.50%2.81% (1.18--4.62)9.83 (4.12--16.17)Retrospective and depression1.30 (1.05--1.62)8.50%2.49% (0.42--5.01)8.70 (1.48--17.52)Self-reported diabetes measure and depression1.37 (1.17--1.60)8.50%3.05% (1.42--4.85)10.67 (4.99--16.98)Blood test diabetes measure and depression1.25 (1.04--1.52)8.50%2.08% (0.34--4.23)7.28 (1.19--14.82)[^2]Fig. 4Potential depression cases that could be prevented through diabetes reduction worldwide estimates based on various study designs.Fig. 4

4. Discussion {#s0090}
=============

This meta-analysis generally showed that people with diabetes had a greater risk of developing depression compared to those without. Out of the 20 studies involving 547,417 participants, half of them (10 studies) constituting 67.6% of the participant population suggested increased depression risk. The pooled OR between diabetes and depression for all the studies included in this analysis was 1.33 (95% CI 1.18--1.51). The ORs for various study types were: prospective studies OR 1.34 (95% CI 1.14--1.57); retrospective OR 1.30 (95% CI 1.05--1.62); self-reported doctor\'s diagnosis OR 1.37 (95% CI 1.17--1.60) and blood test diagnosis OR 1.25 (95% CI 1.04--1.52). Specific studies that did not find an increased risk of depression generally had smaller sample sizes, had a shorter follow-up period and had an earlier publication date. Conversely, studies that found a relationship between the two conditions had long years of follow-up, larger sample size and published more recently.

Our results are consistent with previous reviews that reported diabetes was a risk factor for depression. The pooled OR of 1.33 reported in this systematic review is higher than the ORs reported in previous meta-analyses of 1.15 (95% CI 1.02--1.30), 1.24 (95% CI 1.09--1.40) and 1.29 (95% CI 1.03--1.63) respectively ([@bb0215]; [@bb0260]; [@bb0330]) but fell short of a two-fold increased risk of depression in diabetes found in a previous meta-analysis ([@bb0030]). Also, our current finding is in keeping with recent bidirectional reviews measuring the relationship between diabetes and depression where a moderate association was found between the two debilitating conditions ([@bb0375]; [@bb0140]; [@bb0305]). Our review is however at odds with a small meta-analysis that involved 3 longitudinal studies which found those with diabetes to have had an insignificant higher risk of developing incident depression compared to controls, RR 1.50 (95% CI 0.92--2.44) ([@bb0075]).

Overall prospective studies using both diabetes diagnosis methods reviewed here found that respondents with diabetes were 34% more likely to develop depression compared to controls (OR 1.34, 95% CI 1.14--1.57) while retrospective study designs found those with diabetes were 1.30 times more likely to develop depression. These findings are consistent with an earlier meta-analysis of seven longitudinal studies where the pooled OR for risk of depression was 1.15 (95% CI 1.02--1.30) ([@bb0215]).

A previous meta-analysis of studies using clinical measures of diabetes reported smaller effects (RR1.11) compared to self-reported studies (RR 1.16) ([@bb0215]). We found that studies using self-report of doctor\'s diagnosis showed a slightly larger effect (OR 1.37, 95% CI 1.17--1.60) than studies that used clinical measures or diagnostic blood tests. Our study is consistent with what has been earlier reported ([@bb0215]). Among the seven studies analyzed here that examined the relationship between diabetes and depression using diagnostic blood tests, we found a pooled OR = 1.25 (95% CI 1.04--1.52). Four of the studies largely from the USA reported a negative relationship between diabetes and depression while three of the studies, from two European countries, reported a positive relationship between diabetes and depression. The literature suggests that while the overall prevalence of obesity among adults has increased in the US, there are significant ethnic or racial disparities with the highest prevalence among the African-American populations ([@bb0270]). We suggest that the sample variations in these studies, oversampling of white or Latino populations, could possibly explain the non-significant results reported.

In our review heterogeneity was large compared to previous reviews ([@bb0215]; [@bb0260]). This could probably be due to the fact that, earlier studies did not report a more increased risk of depression in people with diabetes is currently being reported by later studies owing to differences in clinical and methodological aspects. We cannot authoritatively state why recent studies report an increased risk of depression in people with diabetes. However, a plausible explanation could be that health care professionals and patients with diabetes are increasingly becoming knowledgeable about depression or depressive symptoms in people with diabetes and this could possibly influence responses during follow-up periods. But the results of this study should be interpreted with caution since it is possible that the incident depression reported in this study can be due to recurrence of depressive disorder among those with a history of depression or as a result of diabetes-related complications.

To the authors\' knowledge, this is the first study to provide quantitative estimates on the projected reduction of depression cases that could result from a reduction in the worldwide prevalence of diabetes. The PAFs estimates show a significant number of depression cases worldwide (9.55 million) are potentially attributable to diabetes prevalence. Measures used to reduce the prevalence of diabetes will eventually lead to a reduction in depression and that should be the focus of public health prevention efforts. This study projects that a 10--25% reduction in diabetes prevalence could potentially prevent 930,000--2.34 million depression cases worldwide.

 {#s0095}

### 4.1.1. Strength and limitations of the current study {#s0100}

The major strength of this study comes from the pooled findings of longitudinal cohort studies and the relatively large number of studies involved. The reviewed studies were of high quality. We also provided PAF estimates to show the potential impact of substantially reducing diabetes prevalence on the global incidence of depression. However, the current study has limitations that may affect generalizability. First and foremost, the study is limited by our restriction of the literature search to only studies conducted in the English language since there have been divergent views on the impact of language bias on the quality of systematic reviews. Secondly, our reviewed studies were not geographically representative of the world\'s population. Majority of the studies reviewed emanated from the US, Europe, and other developed countries. There were no studies from Africa, South America, and other developing countries. However, the International Diabetes Federation 2013 report suggested that about 80% of people living with diabetes are resident in low and middle-income countries ([@bb0170]).

In addition, some of our studies failed to adequately adjust for strong moderating factors such as gender, smoking, alcohol abuse, and the presence of other chronic diseases ([@bb0010]). Confounding is possible. Another limitation is the high values of heterogeneity that were recorded in 3 out of the 4 analyses performed in our meta-analysis. This shows substantial variation in the degree of association between diabetes and depression in the studies reviewed. We reported on studies using self-report of doctor\'s diagnosis of diabetes and diagnostic blood tests (fasting plasma glucose or oral glucose tolerance test). Both measures have their respective strengths and limitations. A major drawback of self-reported diagnosis is that it may be an underestimate of the real prevalence of diabetes. On the other hand, it is suggested that a part of the patients classified as having diabetes using diagnostic blood tests (fasting glucose or oral glucose tolerance test) may remain unaware of this diagnosis, thus avoiding the psychological effects of this diagnosis ([@bb0060]).

It is not clear cut that all self-reported diagnosis lead to over or underestimate diabetes prevalence. We assume that the source of the recorded heterogeneity is either clinical or methodological which suggests the need to adjust for known moderators in future studies of the diabetes-depression relationship.

Finally in estimating PAF values the worldwide prevalence of diabetes was not broken down by the severity of complications, we used crude overall prevalence rate to calculate PAFs. Our PAF estimates did not take into account diabetes severity and its effects on complications and their combined effect on depression incidence. Diabetes in itself does not usually cause death directly but rather it is the complications that arise from the disease that has a substantial impact on an individual\'s health.

5. Conclusion {#s0105}
=============

Despite limitations, our systematic review provides fairly robust evidence to support the hypothesis that diabetes is a risk factor in the development of depression and that the risk of depression is higher in people with diabetes compared to the general population. This increased risk reported may be due to recurrence of depression among people with a history of depression or as a result of diabetes-related complications. We also note some of the impacts of risk factor reduction, study design, and diagnostic measurements of exposure of interest. More and better-designed cohort studies are still needed to corroborate our study and to also firmly establish the relationship between diabetes and depression and the possibility of a two-way interaction between these disorders. The calculated PAFs showed that a large reduction in the worldwide prevalence of diabetes could translate into a significant reduction in the incidence of depression. However, this impact is not limited to the incidence of depression but has a larger effect because of the clinical and economic repercussions that come with the long-term management and treatment of both conditions globally. Interventions and services for diabetes prevention such as healthy diet, physical activity, and weight loss also improve the mental health of general populations. This review reinforces the need for a holistic approach toward combating diabetes. Well-managed diabetes could help weaken the association between depression and diabetes.
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[^1]: CES-D Scale: Centre for Epidemiologic Studies Depression Scale. GMS-AGECAT: Geriatric Mental State Schedule Automated Geriatric Examination for Computer Assisted Taxonomy. HADS-D: Hospital Anxiety and Depression Scale. DSSI: Delusions --Systems-State-Inventory. BDI: Beck Depression Inventory^.^

[^2]: OR, Odds ratio; CI, confidence interval; PAF, population attributable fraction.
